94
Views
10
CrossRef citations to date
0
Altmetric
Letter to the Editor

An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation

, , , , , , & , Ph.D. show all
Pages 1034-1037 | Received 29 Dec 2006, Accepted 13 Jan 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Raquel Vinhas, Milton Cordeiro, Pedro Pedrosa, Alexandra R. Fernandes & Pedro V. Baptista. (2017) Current trends in molecular diagnostics of chronic myeloid leukemia. Leukemia & Lymphoma 58:8, pages 1791-1804.
Read now

Articles from other publishers (9)

Florian Ramdohr, Alice Fabarius, Bettina Maier, Daniela Bretschneider, Anna Jauch, Astrid Monecke, Klaus H. Metzeler, Johannes W. G. Janssen, Richard F. Schlenk & Sabine Kayser. (2022) Atypical presentation of patients with chronic myeloid leukemia in chronic phase—Case report. Frontiers in Oncology 12.
Crossref
Monica Piedimonte, Tiziana Ottone, Valentina Alfonso, Antonella Ferrari, Esmeralda Conte, Mariadomenica Divona, Maria Paola Bianchi, Maria Rosaria Ricciardi, Simone Mirabilii, Roberto Licchetta, Alessia Campagna, Laura Cicconi, Giulia Galassi, Sabrina Pelliccia, Annapaola Leporace, Francesco Lo Coco & Agostino Tafuri. (2019) A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review. BMC Cancer 19:1.
Crossref
Mohammad Muhsin Chisti & Daniel Steven Sanders. (2018) Chronic Myeloid Leukemia with b3a3 (e14a3) Fusion: A Rare BCR/ABL Rearrangement Presenting with Thrombocytosis – Does MTHFR Polymorphism Matter. Case Reports in Oncology 11:2, pages 485-492.
Crossref
Yasuhiko Harada, Satoshi Nishiwaki, Takumi Sugimoto, Koichi Onodera, Tatsunori Goto, Takahiko Sato, Sonoko Kamoshita, Naomi Kawashima, Aika Seto, Shingo Okuno, Satomi Yamamoto, Toshihiro Iwasaki, Yukiyasu Ozawa, Koichi Miyamura, Yoshiki Akatsuka & Isamu Sugiura. (2017) Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia. Medicine 96:50, pages e9160.
Crossref
Raquel Vinhas, Alexandra R. Fernandes & Pedro V. Baptista. (2017) Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia. Molecular Therapy - Nucleic Acids 7, pages 408-416.
Crossref
Antonella Zagaria, Luisa Anelli, Nicoletta Coccaro, Giuseppina Tota, Paola Casieri, Angelo Cellamare, Luciana Impera, Claudia Brunetti, Angela Minervini, Crescenzio Francesco Minervini, Mario Delia, Cosimo Cumbo, Paola Orsini, Giorgina Specchia & Francesco Albano. (2015) BCR?ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. Virchows Archiv 467:3, pages 357-363.
Crossref
Zi Chen, Wei Wang, Amy Rich, Guilin Tang & Shimin Hu. (2015) Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases. American Journal of Hematology 90:8, pages E146-E148.
Crossref
Mhairi Mitchell, Doha Itani, Jonathan Gerber, Nilanjan Ghosh, Ivana Gojo & Amer Zeidan. (2013) Thoracic t(9;22)-Positive Granulocytic Sarcoma as Initial Presentation of Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 13:5, pages 619-621.
Crossref
Karolien Anne Beel, Jan Lemmens, Hilde Vranckx, Johan Maertens & Peter Vandenberghe. (2011) CML with e6a2 BCR-ABL1 transcript: an aggressive entity?. Annals of Hematology 90:10, pages 1241-1243.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.